Matt Borsch analyst

Currently out of the existing stock ratings of Matt Borsch, 92 are a BUY (58.23%), 62 are a HOLD (39.24%), 4 are a SELL (2.53%).

Matt Borsch

Work Performance Price Targets & Ratings Chart

Analyst Matt Borsch, has had 85.22% of price targets met with an average potential upside of 23.78%, reached in 450 days on average. Previously, Matt Borsch worked at BMO, GOLDMAN SACHS.

Matt Borsch has documented 313 price targets and ratings displayed on 19 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on AGTI, Agiliti at 10-Aug-2022.

Wall Street Analyst Matt Borsch

Analyst best performing recommendations are on AGTI (AGILITI).
The best stock recommendation documented was for AGTI (AGILITI) on 5/18/2021. The price target of $18 was fulfilled within 6 days with a profit of $2.81 (18.5%), with a performance score of 30.83.

Average potential price target upside

ACHC Acadia Healthcare Company AMED Amedisys ANTM Anthem CI Cigna Corp CNC Centene Corp CVS CVS Health Corp HCA HCA Holdings HUM Humana MD Mednax MOH Molina Healthcare UHS Universal Health Services UNH UnitedHealth Group WCG WellCare Health Plans EHC Encompass Health Corp ELV Elevance Health AGTI Agiliti AVAH Aveanna Healthcare Holdings ADUS Addus HomeCare ADPT Adaptive Biotechnologies Corp

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 14-Jan-2026

$41

$6.4 (18.50%)

$31

15 days ago
(06-Nov-2026)

6/17 (35.29%)

$4 (10.81%)

100

Hold Since 02-Jul-2024

$39

$4.4 (12.72%)

$30

15 days ago
(06-Nov-2026)

8/20 (40%)

$2 (5.41%)

70

Buy Since 09-Apr-2025

$41

$6.4 (18.50%)

$39

15 days ago
(06-Nov-2026)

6/8 (75%)

$4 (10.81%)

205

Hold Since 14-May-2025

$35

$0.4 (1.16%)

$32

16 days ago
(05-Nov-2026)

10/22 (45.45%)

$0.21 (0.60%)

103

Hold Since 23-Sep-2026

$33

$-1.6 (-4.62%)

1 months 29 days ago
(23-Sep-2026)

9/14 (64.29%)

$4.49 (15.75%)

364

Show more analysts

Please expand the browser size to see the chart

✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?